BioCentury
ARTICLE | Company News

Biotronik sales and marketing update

September 9, 2013 7:00 AM UTC

Biotronik launched 35 and 40 mm versions of its Orsiro Hybrid Drug-Eluting Stent in countries that recognize CE Mark approval to treat coronary artery stenosis. The product is a BIOlute-coated stent ...